chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had abdominal cramping. I've had about 3 episodes this morning; swelling in my armpit; some muscle soreness; soreness at the injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 56-year-old patient received BNT162b2 (COMIRNATY), on 07Jun2022 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 56 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (First Booster ; unknown manufacturer), for COVID-19 Immunization. The following information was reported: MYALGIA (non-serious) with onset 08Jun2022, outcome "unknown", described as "some muscle soreness"; VACCINATION SITE PAIN (non-serious) with onset 08Jun2022, outcome "unknown", described as "soreness at the injection site"; SWELLING (non-serious) with onset 08Jun2022, outcome "unknown", described as "swelling in my armpit"; ABDOMINAL PAIN (non-serious) with onset 09Jun2022, outcome "unknown", described as "had abdominal cramping. I've had about 3 episodes this morning".  Additional information: I got my 2nd booster of Comirnaty on 07Jun2022.Patient weight was reported as 113. Patient tried to use the app for this but it kept losing information. Patient also called the toll-free number and it was a fax.~  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
After 1st Dose patient had a headache for several days.  After 2nd dose patient has started with a migraine that will not go away with any OTC treatment in addition to dizziness x 4 days.
Appendicitis Emergency Appendectomy performed on 10/31/2021 Severe abdominal pain, hurt to move, to touch  Eye Pain Significant GI distress
Patient should have received COVID19 PFIZER UPDATED BOOSTER 12+(BIVALENT) and received COVID19 (PRIZER AGE 12+) GRAY CAP.  PATIENT EXPERIENCE A RASH/HIVES THAT WERE TREATED WITH ORAL STERIODS, PRESCRIBED BY AN URGENT CARE FACILITY.
Petechial rash on chest. No itch. Prednisone tapering dose & BENADRYL.
Pt. developed a generalized red rash over the entire body with mild itching. Onset was 5 days post-vaccine administration. No sob or airway swelling/rash. Pt. visited his dermatologist who suspected that the rash was secondary to an ingredient in the vaccine. The pt. was advised by the dermatologist to not take the 2nd dose.
Bilateral hand weakness, joint stiffness in the hands and elbows, fatigue, petechiae on right arm/chest.
Red arm 12 cm Nausea Fever to 100.5 Fatigue chills myalgia
13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 ml. On 25-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Oct-2021: Follow Up received contains No New Information.
Information has been received from a medical assistant concerning an 18 year old female with a history of dysfunctional uterine bleeding (DUB) and anaemia who on 14 Sep 2006 was vaccinated with HPV vaccine (lot 0800F, batch 654540), 0.5 ml, IM, once. Concomitant therapy included Yasmin. In approximately November 2006 (last couple weeks), the patient experienced extreme eye dryness after receiving HPV vaccine. The patient's eye was so dry that she had a hard time seeing. On an unspecified date, the patient sought unspecified medical attention. Eventually, the patient had a duct implant put in her eyes by a specialist to help with the dryness. The patient was recovering from the event of extreme eye dryness. Extreme eye dryness was considered to be disabling and an other important medical event (OMIC). Additional information has been requested.
Two days after receiving my second covid shot, I began noticing rapid heart beat when at rest. These are not typically times that experience this...while laying down, driving, sitting etc. Over the next couple of days I noticed more issues such as shortness of breath and a pinching feeling in my chest. I also noticed during this period of time that I was unable to complete my typical cardio routine in the gym, that I have been doing for years, due to the shortness of breath and rapid heart beat.  I experienced the pinching feeling in my chest, flutter and tickle sensation as well. I would not describe this as painful, but rather unusual, unsettling and abnormal. I have not experienced these sensations before. On 10/9, I experienced a, "dipping," feeling or skipped heartbeat upon waking in the morning.
A bump at the site of administration of the vaccine; A 3 inch rash at the site of administration of the vaccine; This spontaneous case was received on 24-Sep-2020 from other non-health professional via agency (reference number: SEQW20-02263) and concerned a patient of an unknown age and gender.  The patient's medical history and concomitant medications were not reported.   On 17-Sep-2020, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid) for influenza prophylaxis. The batch number was 283849, expiry date: 30-Jun-2021.   On the same day, after receiving Flucelvax QIV, the patient developed a bump and a 3-inch rash at the site of administration of the vaccine. The patient did not receive any treatment measures associated with the events.  On an unspecified date in Sep-2020, the patient recovered from the events.  The reporter did not provide a causality assessmen to Flucelvax QIV.   The case was assessed as non-serious.  This case is linked to cases 202004696, 202004697, 202004698, 202004699, 202004700, 202004701, 202004702, 202004703, 202004704, 202004705 and 202004706 due to the same reporter.  Additional non-significant information received on 06-Jan-2021 from other non-health professional via agency (reference number: SEQW21-00065) with additional information received on 12-Jan-2021 from other health professional (reference number: SEQW21-00149) (being processed together): Two reporters were added. Reference numbers added. No changes in narrative.  Company comment: The patient developed vaccination site mass and vaccination site rash on the same day after vaccination with the suspect product, Flucelvax QIV. Chronology is suggestive. No information regarding concomitant medications and medical history was provided. Considering all information above, causal relationship for both events is assessed as possibly related. (defaults to ''related''in the safety database for reporting purposes).; Sender's Comments: The patient developed vaccination site mass and vaccination site rash on the same day after vaccination with the suspect product, Flucelvax QIV. Chronology is suggestive. No information regarding concomitant medications and medical history was provided. Considering all information above, causal relationship for both events assessed as possibly related. (defaults to "related" in the safety database for reporting purposes).
LMP, 02/26/2021 -- > EDD 12/03/2021 Patient stated vaginal discharge, 06/02/2021 Miscarriage @ 13 + 5  D & C, 06/28/2021
About 2 days after the vaccine, I had flu like symptoms of feeling tired, fatigue, difficulty concentrating.  I had these symptoms on and off which lasted until September 2021.   I check my sugars at home daily and noticed my sugars are high around 200-450.  My blood pressure is also high about 150/96.  I did go see my doctor and was prescribed amlodipine 5mg to start.  A few week later, amlodipine was increased to 10mg.  I also had swollen ankles and was prescribed metoprolol for that.  The blood pressure is coming down.  For the diabetes, the doctor increased my insulin dosage and now my sugar readings are around 200-240.   I have to get an eye exam.  I also get headaches.
Bells Palsy; numbness on the left half of the face / numbess from left eye to left jaw / numbess from left half of the nose to the left ear; cannot taste food; This case was reported by a consumer via call center representative and described the occurrence of bell's palsy in a 62-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   On 22nd October 2020, the patient received the 1st dose of Shingrix and the 1st dose of Influenza vaccine Quadrivalent 2020-2021 season. On 22nd October 2020, less than a day after receiving Shingrix and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced bell's palsy (serious criteria GSK medically significant), numbness facial and taste loss. The patient was treated with steroids nos (Steroid (Not Specified)). On an unknown date, the outcome of the bell's palsy, numbness facial and taste loss were unknown.   It was unknown if the reporter considered the bell's palsy, numbness facial and taste loss to be related to Shingrix and Influenza vaccine Quadrivalent 2020-2021 season.  Additional case details were reported as follows: The patient reported case for himself. The patient received Shingrix vaccine in the right arm and the flu shot in the left arm. The patient received the first dose of the Shingrix and a flu shot on a Thursday, few days before day of reporting, and experienced numbness on the left half of the face, numbness from left eye to left jaw and numbness from left half of the nose to the left ear. The patient could not taste food. He was seen at the urgent care on 22nd October 2020 and was started on steroid. The patient got a pneumonia vaccine on the following Tuesday and that was the day, he came to know that he had numbness on the left half of his face. The patient did not know the name of the other vaccines and also he was not sure of the dates of the vaccines and also did not know the lot and expiration date of the vaccines. The reporter consented to follow up.
+12 to 13 hours: Feeling hot, sweating +15 to 24 hours: Chills +15 to 36 hours: Lethargy, fatigue, aching joints +36 to 48 hours: Lethargy
Within a minute of Gardasil Vaccine she fainted with eyes open and dilated at full extend, started convulsing for 5 seconds, eyes started to shake also.
sinus infection; This is a spontaneous report received from a contactable consumer (patient) via Medical Information Team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on 30Jan2021 as a dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, the patient had received the first dose of the Pfizer COVID-19 vaccine on 30Jan2021. Stated that, the patient developed a sinus infection on an unspecified date in 2021, which was not from the Pfizer COVID-19 Vaccine, had no connection to the vaccine-she gets these kind of sinus infections normally. Stated that, she was prescribed and taking Amoxicillin for the sinus infection until taking the last tablet last night. Stated that, she took the last dose of her antibiotic yesterday. She was scheduled for her second dose of Pfizer COVID-19 Vaccine tomorrow (on 20Feb2021). Stated that, she called to ask whether the Amoxicillin taken will interfere with the Pfizer COVID-19 Vaccine. Stated that, she just wanted her inquiry to be addressed at this time, that was to know whether there was any interaction or was it contraindicated in taking the vaccine. The reporter considered the events as non-serious. Treatment was received for the event. The outcome of the event was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
I first noticed my arm was very itchy. Upon further inspection, I noticed a softball sized wheal and the area was erythemic. Later that day (around noon), I noticed I was having some slight wheezing. The intercostal joints in my chest felt stiff and painful to breathe (this resolved the next day), and I developed a moderate amount of pain/sensitivity to my right arm (where the vaccine was administered). The area continued to itch a lot. The wheal lasted approx. 5 days and the itchiness continued for just over a week.
Temperature: 99 F, muscle aches, "feeling lousy", lymphadema, local redness, bump at site, whitish blaster, local itching, malaise and fatigue worse than expected; pain right oxilla.  Benadryl; limited activity and duty
Developed cellulitis in left upper arm from site of injection to below elbow. Required antibiotics. Arm swollen, red moving down arm, hot, painful, fever, nausea, achiness.
Elevated, red, warm rash at injection site. Don't know if related but also red patchy site at nape of neck.
pt recv 1 dose of varivax 4/15/98 & 4/17 pt devel a couple of lesions. 4/20 pt presented w/full blown chickenpox.
Pt got a rash all over her body and face.  Pt c/o swollen area behind her right ear that was painful.  Symptoms lasted 3-4 days.
Patient presents to the clinic for a nurse visit per this RN's request for a reported reaction to a immunization Pneumococcal 23 given in clinic 5/21/19 during a MWV. Patient states that her physical therapist had noticed the redness under her arm and had advised her to contact our clinic. On examination of Patient's right arm it is noted that she has a small red spot from the injection toward the bottom of her deltoid. No erythema of swelling at injection site. There was two faint lateral red streaks extending to the underside of her arm pit. The redness in her arm pit was approximately 2 inches by 1 inch, tender to touch, slight warmth. Because the area is tender touch, red and has evidence of creeping discoloration I did ask a provider to examine. NP examined Patient, NP encouraged Patient to try warm compresses to her underarm, monitor for increased swelling, pain or redness. Advised if her symptoms worsen or do not resolve she should go to a Urgent Care to be seen. Patient agreed with the plan. This RN drew a circle around the erythema in her underarm for measure and monitoring. A Vaccine information sheet was provided with information about mild to sever injection site reactions. Informed I will put in the VAERS. This RN also verified that the vaccine provided had not expired and had been stored at the appropriate temperature.
Sense of smell has been altered. Some things smell very unusual. All things that smell unusual,  smell the same. Some include: dairy products, coffee, red wine
Information has been received from a consumer concerning her 17 year old daughter with no pertinent medical history and no drug reactions/allergies who in March 2007, was vaccinated with Gardasil (lot# unknown).  There was no concomitant medication.  In May 2007, the patient received her second dose of Gardasil (lot# unknown).  The caller reported that on 30-JUL-2007 the patient experienced a miscarriage when she was 2 and 1/2 months pregnant.  Caller was not aware as to when the patient learned about her pregnancy.  Caller reported that the patient missed the third dose of Gardasil vaccine which was supposed to be given to her in "October 2007".  The patient's LMP was approximately 22-OCT-2007 and is now 3 months pregnant again.  The patient's estimated date of delivery is "July 2008".  No further information was provided.  Upon internal review miscarriage is considered to be an other medical event (OME).  No further information is available.
after 5-6 minutes after receiving vaccine pt started sweating and feeling dizzy.  got pt water and cold compresses. had pt to lie down and put compresses on face and neck.  after several minutes pt started feeling better so had pt sit up but pt started feeling dizzy again so pt lied down again.  went through this process several times until pt was able to remain upright without feeling dizzy.  pt remained in pharmacy for around 40-45 minutes.
My wife (a RN) and I had flu shots two days apart and at different facilities.  Since a week ago we have both had violent vomiting, high fever, continuous diarrhea and bouts of extreme shivers.  The condition continues for both of us.  Great vaccine!  Neither of us will ever get another flu shot.  Neither of us were sick prior to the vaccine injection.  We have both had flu shots for many years prior with no adverse reactions.
Low grade fever (99.5), aches, chills, nausea.  Arm didn?t hurt as bad as 1st vaccination, but other symptoms were worse.
This case was reported by a healthcare professional (medical assistant) and described the occurrence of expired vaccine used in a 56-year-old subject of unspecified gender who was vaccinated with TWINRIX (GlaxoSmithKline). On 13 December 2013 the subject received a dose of TWINRIX (unknown details) and experienced expired vaccine used. The expiry of TWINRIX was 5 October 2013). Per the reporter, there were "no symptoms reported".
Swelling and redness of face, some general itchiness Feb9, and 10th. Swelling and redness of face Feb 11th.
Initial report received on 14 August 2009 from a health professional. A 35 year old patient, with an allergy to ASA, received a left deltoid 0.5 ml intramuscular injection of DAPTACEL (lot number C3141AA) on 12 August 2009. DAPTACEL had been administered instead of ADACEL. The patient had no illness at the time of vaccination. Concomitant medications included CELEXA (reported as SELEXSA), PREVACID, NASACORT. Twelve hours after vaccination, the patient had a fever (specific temperature unknown) and chills for twelve hours. Corrective treatment was not reported. The events resolved after 12 hours without further complaints.
12 hours after my injection I had very strong  chills and maybe a fever which lasted approximately 3.5 hours followed by a low grade headache which lasted several hours. The following day I was fine.
having red splotch appear like a raised pancake on the skin; splotch receded it turned into a rash,rash is appearing 1/2 an inch from the injection site which aligns with the black; This spontaneous case was reported by a patient and describes the occurrence of RASH MACULAR (having red splotch appear like a raised pancake on the skin) and INJECTION SITE RASH (splotch receded it turned into a rash,rash is appearing 1/2 an inch from the injection site which aligns with the black) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     The patient's past medical history included Lyme's disease in 2009 and Spider bite ((~3-4 years ago)). Concomitant products included ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), MELALEUCA VIRIDIFLORA ESSENTIAL OIL, FISH OIL and LINUM USITATISSIMUM OIL (FLAXSEED OIL [LINUM USITATISSIMUM OIL]) for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced RASH MACULAR (having red splotch appear like a raised pancake on the skin) and INJECTION SITE RASH (splotch receded it turned into a rash,rash is appearing 1/2 an inch from the injection site which aligns with the black). At the time of the report, RASH MACULAR (having red splotch appear like a raised pancake on the skin) and INJECTION SITE RASH (splotch receded it turned into a rash,rash is appearing 1/2 an inch from the injection site which aligns with the black) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included Areds green, Areds yellow.  Treatment information was not provided.   Reporter did not allow further contact
Approximately 12 hours after the Tdap injection of the vaccination I began having extreme pain in my neck, back, arm and hand. It was a deep soreness and inflammation at the injection site. A short time later I acquired a red rash and blotchiness on my entire upper arm. I was then seen by an Urgent Care Doctor as well as a Doctor at the Emergency Room on 05/16/2014 around 8:00 PM.
Dizzy spells, diarrhea, cold chills, hot sweats, period came on never went off for 2 1/2 wks. heavy clotting and bleeding, migraine headaches, constipation at times, memory loss, like a fuzziness in the head and off balance at times, tingling in the ear (left), flu like symptoms. Follow up on 11/25/03: "To whom it may concern: I have requested copies of medical record from hospital which I will send later.  If you have questions, please feel free to contact me.  I am still waiting for LOD form to be filled at by my unit investigating officer, so as soon as she does that it will be also sent to you."
This case was reported by a consumer via call center representative and described the occurrence of weakness in a 55-year-old female patient who received Shingrix for prophylaxis. Co-suspect products included Fluarix Quadrivalent 2018-2019 season for prophylaxis. Previously administered products included Flu vaccine (No adverse event). On 15th September 2018, the patient received Shingrix and Fluarix Quadrivalent 2018-2019 season. On 15th September 2018, 2 hrs after receiving Shingrix and Fluarix Quadrivalent 2018-2019 season, the patient experienced weakness, lethargy, chills, tremor, pain in arm, injected limb mobility decreased, activities of daily living impaired and tiredness. On an unknown date, the outcome of the weakness was recovering/resolving and the outcome of the lethargy, chills, tremor, pain in arm, injected limb mobility decreased, activities of daily living impaired and tiredness were unknown. It was unknown if the reporter considered the weakness, lethargy, chills, tremor, pain in arm, injected limb mobility decreased, activities of daily living impaired and tiredness to be related to Shingrix and Fluarix Quadrivalent 2018-2019 season. Additional details were provided as follows: At 3:00 pm, the patient received Shingrix on right side. The patient experienced pain in her right arm at rest and got worse with movement. The patient stated that she lost some function in her arm and was not able to fully raise her arm and she was extremely weak, tired, was shaking to the point of not being able to complete normal routines like driving. The patient stated she had severe chills. The patient stated she received the Flu vaccine at the same Pharmacy visit on her left arm and never had any adverse events to the Flu shot. The patient did not start feeling better until Monday morning (day of reprting).